|
مقاله
|
Abstract
|
|
|
|
Title:
|
A Review of the Outcomes of Idiopathic Intracranial Hypertension Treatment
|
|
Author(s):
|
Alipanahi Rakhshandeh MD, Sayyamelli Sara MD , MD Sayyahmelli Sima MD , Ghasemi Houshang MD
|
|
Presentation Type:
|
Poster
|
|
Subject:
|
Strabismus & Neuro-ophthalmology
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Rakhshandeh Alipanahi
|
|
Affiliation :(optional)
|
Associate Professor of Ophthalmology
|
|
E mail:
|
ralipanahi@yahoo.com
|
|
Phone:
|
04135562600
|
|
Mobile:
|
09141140374
|
|
|
|
|
Purpose:
|
The Idiopathic Intracranial Hypertension Treatment was the first large, randomized study on the use of acetazolamide and weight loss for treatment of idiopathic intracranial hypertension-associated vision loss
|
|
Methods:
|
We performed a PubMed literature search for all articles with data from the IIHT Study Group.
|
|
Results:
|
The PubMed search identified 12 articles with primary and or secondary outcome data from the IIHT. We summarized the findings for the primary outcome of visual field outcomes in the acetazolamide treatment group compared to the placebo group, as well as secondary outcomes for the safety and tolerability of acetazolamide, cerebrospinal fluid opening pressure, quality of life, fundus photography, and optical coherence tomography.
|
|
Conclusion:
|
Most importantly, it provided support for the safe use of acetazolamide up to 4 g daily with weight loss for effective treatment of mild vision loss in IIH, with associated improvements in papilledema, increased intracranial pressure, and quality of life
|
|
Attachment:
|
65A Review of the Outcomes of Idiopathic Intracranial Hypertension Treatment.key
|
|
|